Identity reference · Published July 22, 2026 · Compliance review August 20, 2026

Tirzepatide identity and analytical reference

Tirzepatide is a synthetic modified peptide identified in the literature as LY3298176 and by CAS 2023788-19-2. This page is limited to nomenclature, material identity, and analytical-documentation boundaries.

Scope boundary: this page documents nomenclature and analytical-documentation limits. The catalog product is offered only for lawful nonclinical laboratory research and is not for human or veterinary use.

What is Tirzepatide?

LY3298176 is the development identifier associated with tirzepatide in the cited literature. The catalog shorthand “GLP-2” is not a complete chemical identifier. Use the full material name, CAS registry number, and lot-specific documentation when identifying a supplied material.

Research category

Peptide identity & analytical references

Reference scope

Nomenclature, molecular identity, and analytical characterization

Names in the literature

Tirzepatide; LY3298176

Primary boundary

A literature name or identifier does not verify the identity, purity, composition, or intended use of a separate lot.

What does the cited reference establish?

The cited discovery paper documents the authors' molecular design and study-material identity. It is not a batch report for an independently supplied material. Lot-linked analytical documentation and fit-for-purpose verification are required for a supplied batch.

Primary sources

1. Coskun et al., Molecular Metabolism (2018) — Primary literature identifying LY3298176 and describing the molecular design of the study material. DOI: 10.1016/j.molmet.2018.09.009

Research literature and product documentation are different

A publication describes a study and its results. A batch-specific Certificate of Analysis documents characteristics of a supplied research material. One does not substitute for the other.

Browse the COA library · Read the research-use policy

Prepared by The Pep Labs Research Editorial Team. This identity reference contains no preparation, dosing, administration, or human-use guidance.